Brief: Oncology Institute's Board Approved Share Repurchase Program
June 15 (Reuters) - Oncology Institute Inc TOI.O :
* ONCOLOGY INSTITUTE - ON JUNE 14, BOARD APPROVED SHARE
REPURCHASE
PROGRAM WITH AUTHORIZATION TO PURCHASE UP TO 5 MILLION SHARES OF
CO'S COMMON STOCK
Source text for Eikon: ID:
Further company coverage: TOI.O
Recent news on Starling Oncology
See all newsBrief: Starling Oncology Unit Enters Credit Agreement On August 20
Brief: Starling Oncology Q2 EPS USD -0.08
Brief: Oncology Institute Rebrands As Starling Oncology
Oncology Institute Q1 revenue rises on specialty pharmacy growth, reaffirms 2026 revenue guidance
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million